SCIENTIFIC LITERATURE · MED

Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.

Eggert K, Öhlwein C, Kassubek J, Wolz M, Kupsch A, Ceballos-Baumann A, Ehret R, Polzer U, Klostermann F, Schwarz J, Fuchs G, Jost W, Albert A, Haag A, Hermsen A, Lohmüller K, Kuhn K, Wangemann M, Oertel WH, In Cooperation With the German Competence Network on Parkinson’s Disease.

Clin Neuropharmacol · 2014-07-01

DOI: 10.1097/wnf.0000000000000041PMID: 24992083

Check source for accessClinical Trial, Phase III; Comparative Study; Research Support, Non-U.S. Gov't; Randomized Controlled Trial; Journal ArticleOriginal source ↗

Research overview

Read the abstract at its original source.

A license permitting republication of the abstract has not been verified for this record. Follow the original publication using its title, authors and identifiers.

Read the original publication ↗

Scientific assessment

Research question

Assess the question within the original study’s scope.

Methods & sample

Check the source article for study design and sample details.

Key findings

An editorially approved findings summary is not yet published for this record.

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.